Paola Principe-Nicolas is President & Founder of P&P PharmaConsulting (www.pnp-pharmaconsulting.com), a boutique consultancy whose mission is to provide expert support for the development, registration and marketing of healthcare innovative solutions.
Paola has spent 27+years in the Pharma Industry where she created value in leading the execution of numerous innovative R&D product strategies (via integrated research, pre-clinical, CMC, pharmaceutical, clinical, registration, marketing & commercialization plans) as well as in securing the life cycle management of medicinal and biological products, at global level.
Key achievements include the successful registration & commercialization of two MAAs and two NDAs (oncology, neurology and endocrinology indications) and the championing of strategic business alliances with partners such as Roche (HCPT™, oncology), Debiopharm (Decapeptyl®, oncology) GTx+Orion (Acapodene®, oncology), Santhera (Fipamezole, neurology), Valeant+Galderma (Dysport®, neurology & aesthetic medicine).
Academically, Paola holds a Laurea Degree in Biological Sciences (University of Rome, Italy) and a PhD in Cell Biochemistry (Middlesex School of Medicine, London, UK). Professional qualifications include certifications in Pharmaceutical Marketing (ESCP Business School, Paris, France), Project Management Professional (Project Management Institute, USA) and Certification of Achievement-Alliance Management (Association for Strategic Alliance Professionals, USA). Paola is fluent in Italian, English & French.